Safety profile of standard- vs. high-dose peginterferon alfa-2a plus standard-dose ribavirin in HCV genotype 1/4 patients: pooled analysis from 5 randomized studies

Author： Marcellin Patrick   Roberts Stuart K   Reddy K Rajender   Harrison Stephen A   Jensen Donald M   Hadziyannis Stephanos   Diago Moises   Weltman Martin   Messinger Diethelm   Tatsch Fernando   Rizzetto Mario  

Publisher： Informa Healthcare

ISSN： 1474-0338

Source： Expert Opinion on Drug Safety, Vol.11, Iss.6, 2012-11, pp. : 901-909

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Virological Response in Patients with Hepatitis C Virus Genotype 1b and a High Viral Load: Impact of Peginterferon-α-2a plus Ribavirin Dose Reductions and Host-Related Factors

By Yamada Gotaro  

Clinical Drug Investigation, Vol. 28, Iss. 1, 2008-01 ,pp. : 9-16

Adis International

Access to resources Recommend Favorite

Efficacy and Safety of Fenofibric Acid Co-Administered with Low- or Moderate-Dose Statin in Patients with Mixed Dyslipidemia and Type 2 Diabetes Mellitus: Results of a Pooled Subgroup Analysis from Three Randomized, Controlled, Double-Blind Trials

By Jones Peter H.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 2, 2010-04 ,pp. : 73-84

Adis International

Access to resources Recommend Favorite

Clinical Effectiveness and Cost Effectiveness of Tailoring Chronic Hepatitis C Treatment with Peginterferon Alpha-2b Plus Ribavirin to HCV Genotype and Early Viral Response: A Decision Analysis Based on German Guidelines

By Siebert Uwe   Sroczynski Gaby   Aidelsburger Pamela  

PharmacoEconomics, Vol. 27, Iss. 4, 2009-06 ,pp. : 341-354

Adis International

Access to resources Recommend Favorite

The current role of high-dose imatinib in chronic myeloid leukemia patients, newly diagnosed or resistant to standard dose

By Breccia Massimo   Alimena Giuliana  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 13, 2011-09 ,pp. : 2075-2087

Informa Healthcare

Access to resources Recommend Favorite

Safety Profile of Tinzaparin Administered Once Daily at a Standard Curative Dose in Two Hundred Very Elderly Patients

By Pautas E.  

Drug Safety, Vol. 25, Iss. 10, 2002-01 ,pp. : 725-733

Adis International

Access to resources Recommend Favorite